So (in our opinion) the time has come — for a whole bunch of reasons — for actual and potential prostate cancer patients to start asking their urologists about whether they are able to carry out transperineal as opposed to transrectal biopsies. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer | Tagged: benefit, biopsy, risk, transperineal, transrectal | 12 Comments »
First and foremost, we would like to thank Prof. Ghulam Nabi of the University of Dundee for providing us with a preprint of the full text of his team’s article on transrectal SWE within about 30 seconds of receiving our request! That’s a record! … READ MORE …
Filed under: Diagnosis, Risk | Tagged: Diagnosis, elastography, risk, shear, transrectal, ultrasound, wave | Leave a comment »
Just this morning, the University of Dundee issued a media release that included the following statement:
an ultrasound process called shear wave elastography (SWE) has been shown to offer much greater accuracy and reliability in diagnosis of prostate cancer, while being a non-invasive and cheaper method than those currently used.
Filed under: Diagnosis, Risk | Tagged: detection, Diagnosis, elastography, shear, SWE, transrectal, wave | 1 Comment »
Contrast-enhanced, transrectal ultrasound (CE-TRUS) technology has been found to better detect high-grade prostate cancer than conventional forms of TRUS, which may make it a more appropriate method for the diagnosis of clinically important cancers and monitoring low-risk ones with less biopsies. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: biopsy, CE-TRUS, contrast-enhanced, Diagnosis, systematic, targeted, transrectal, TRUS, ultrasound | 2 Comments »
A new report from an Italian clinical research team, and based on a randomized clinical trial of 300 patients, suggests that color Doppler ultrasound offers no significant benefit over standard “gray-scale” ultrasound in the biopsy-based diagnosis of prostate cancer — which is not going to please the advocates of color Doppler ultrasonography. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: biopsy, color Döppler, Diagnosis, guidance, SonoVue, transrectal, ultrasound | 4 Comments »
A new paper in Urologic Oncology, taken in combination with a media release and a video release from the UCLA Health System, have described a sophisticated method of combining data from magnetic resonance imaging (MRI) of the prostate with a three-dimensional (3D) ultrasound system to optimize outcomes of prostate biopsies. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: Artemis, biopsy, magnetic resonance imaging, MRI, three-dimensional, tracking, transrectal, ultrasound | Leave a comment »
In today’s other news reports there are items on:
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: biopsy, docetaxel, mistrust, oblimersen, pelvic lymph node dissection, PLND, three-dimensional, transrectal, ultrasound-guided | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 